Correlation Between DiaMedica Therapeutics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Akero Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Akero Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Akero Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between DiaMedica and Akero is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Akero Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to under-perform the Akero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, DiaMedica Therapeutics is 1.59 times less risky than Akero Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Akero Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 2,867 in Akero Therapeutics on August 24, 2024 and sell it today you would earn a total of 253.00 from holding Akero Therapeutics or generate 8.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Akero Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Akero Therapeutics |
DiaMedica Therapeutics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Akero Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Akero Therapeutics vs. Lyra Therapeutics | Akero Therapeutics vs. Hookipa Pharma | Akero Therapeutics vs. Cingulate Warrants | Akero Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |